Member Info for Safy

82p Ask

If Mologic can CE LFT and our TT is complete by end of the year this can be higher than 200p imv

Ignore the title, forum doesn’t do foreign text.. lol replaces it with ???

Zuò dé hao de odx

Alistair is the CEO, if he doesn’t know when his test is coming out I’d be worried. There is no risk if you had inside information.

This is an ODX board, what are you doing here?

Sneakysimon said it first. This is an ODX board. I’m entitled to contribute to any thread on this board.

I don’t give financial advice, but I do give constructive feedback. Still awaiting your answer...

he’s the CEO, he knows everything...as you guys claim he’s in with government.
AVACTA punters think their test is due very soon, every time Boris or government say LFT Avacta think it’s them.

Why would you sell shares and miss two or three bags for the sake of a month?

Vegas

I’d never top slice if I know ODX was going to bag two or three times in 30 days.

Would you top slice if you knew you were going to double or triple bag in 30 days as you had inside information?

Badeli

Given that Avacta claim they are very close to having their test to market. If you had a holding there which you had inside information on, and you knew you were very close to doubling or tripling your investment in 30 days would you reduce your holding to buy a house now or wait?

4% isn’t £40, it’s a substantial amount, now double or triple it and go figure how significant it becomes. Unless you knew it wasn’t happening anytime soon. For the record I’m not saying its either. Just applying my own logic.

If Colin sold shares in ODX right now I’d be worried to.

You may have a point, could be your local test centre, turn up, do a test in the car and show the result. Its then recorded. Or going to collect a POC test at your test centre for some people and its recorded when they give you the test only for you to do it at home. NHS and care homes may have completely different rules.

Eventually it will be purely home test. This government hasnt got the money to keep having centres open and Boris is a true believer in people using common sense.

Omega Diagnostics (LON: ODX) – Its big immediate opportunities are around rapid COVID-19 antibody and antigen tests. While the financial benefit of the antibody test is somewhat shackled by a UK Rapid Test Consortrium agreement – it still has potential to drive mass volume even when a vaccine lands. In the meantime, like Avacta is also looking to cater for the demand for rapid antigen saliva-based testing but via a commercial partnership with Mologic. It also recently told investors it was looking for a significantly improved second half of the year and to scale up production to 2 million tests per week by April without no further placings. Whatever happens, we’d expect its order books to be filled. It has even had very early talks with Avacta.

Key word being ‘immediate’

1m test order already fulfilled

£10m given by gov to get prepped for next order

£75m order value declared - basically incoming

Twatcher

Mologic have a 40m a year capacity

Boris was talking about innova tests more than likely.

Boris may have said days but that translates to weeks. 10 days doesn’t seem like a lot but it’s 2 working weeks. 20 days isn’t a lot of days but it’s a month. Salford was supposed to have rapid saliva tests weeks ago, can you point me to where those tests are?

A lot of it is hope and good will.

However I will say look at the SP for ODX. Nobody here expects it to be our tests first, look at the innova test and limitations to what it can and can’t test. Nobody inc the government are expecting a silver bullet, but what we absolutely know is where Boris wants to take a moonshot, we have a test that fits the bill.

When that Mologic test is ready the SP isn’t going to be 70p.

This isn’t an endorsement to buy ODX, dyor.

https://formlabs.com/uk/covid-19-response/covid-19-rapid-diagnostics/

Rob

Your worry about big pharma beating everyone is valid.

Simple answer for you, Mologic are the equivalent to big pharma in the diagnostic world. They are not a Mickey Mouse company.

Aframaman and the other chap who assumed I’ve got stung on AVCT. .

No I have not got stung by Avacta. If anything going from from 127 to 70p on ODX is getting stung. But I’m still here.

What I post regarding Avacta is facts. And to date not one person has been able to prove me wrong.

Mologic have a 40m capacity. What is Avacta capacity?
Why would CEO cash in early if he could 2x or 3x his money in 30 days or less?
How can Avacta be ahead if nobody has seen their test?
Yes it is ‘our test’ we have an agreement with Mologic.
When we have a presentation with large parts dedicated to Mologic test, how can we pretend it’s anything otherwise?
If it was ‘other’ companies capacity then how hard is it to write Avacta or other Antigen LFT on the graph?
BAMS selling for research, the government are fully stocked up with PCR type lab tests. GDR also have a PCR lab test which is gold standard but getting sales traction is incredibly difficult borderline impossible.
People have no idea how these testing rigs are set up, you can’t just chop and change tests. If it’s not broke don’t try to fix it comes to mind.
Mologic and ODX are not too proud to admit that when a product fails to get to traction like our Elisa we admit it. Mologic are favouring antigen LFT development over Saliva Elisa. Yes I’ve researched that too. Because antigen LFT makes lab test redundant.

End of the day it’s about making money for pi’s. I don’t believe these first round of gov tests are Mologic, in fact I’m convinced they are not. If people want to question my impartiality then that’s the second negative thing I have said regarding ODX. However my hope is that from the UK we are one of a few that make it to the finish line very soon.

I know our TT can be done in 4 weeks worst case a tad more. I got that from ODX directly, again that’s research. Mologic said CE mark in Oct, we are now in November. The CE mark should be very close.

The government is buying Innova LFT which provides a function but fail miserably at everything else... but they are still better than what is out there. I don’t expect perfection but I do expect Mologic will have a test ready very soon.

People under estimate Mologic capabilities in the LFT space and in my eyes wrongly assume that somehow ODX will forgo the chance with Mologic and settle for second. I will add on more thing, if Avacta TT takes 3-4 months, that would take us to March before we have a test. We wouldn’t be trying to get to 2m in April without a test to make. Infact ODX don’t need to hire anybody till early next year because we don’t need them. We need staff now.

Staff overhead is over 200k a month at ODX with 100 staff, at 200 staff it’s close to 500k. Please logically think about this, IF we were going to wait for Avacta then are we prepared to throw away over £1m and have staff twiddling thumbs and wait till March next year.

That logic just doesn’t make any sense.

My own opinion is perhaps markets will take a hit if the lockdown isn’t factored into last weeks terrible losses. France and Germany lockdowns didn’t really affect our market... UK market was flat on Friday.

But remember ODX is part of the solution, anyone with any sense can see that in 1-2 weeks we should see the Mologic CE mark and from then it’s truly Game On!!

P.S this isn’t an endorsement to buy shares here. But Mologic‘S own presentation said CE mark in October. That presentation was delivered around 2 weeks ago.

At the moment there is no official cooperation with Avacta to make anything.

Let me put this into context, Mologic can make 800k a week right now once their test is CE.

Even IF Avacta had a test, they can make a grand total of 0.

Mologic as I’ve said before are ahead of Avacta. Avacta don’t have a test. Their CEO cashed in some shares a few weeks ago, let me tell you something... if there was even a 50% chance he could double or treble his money by holding on for a month why wouldn’t he? You have to be absolutely stupid to miss that sort of opportunity. Except he cashed in. So either people have to accept he’s stupid or there is no test, because if there was a test no way would he cash in.

Let me make that even more simple. Would I sell my ODX shares if there was at least a 50% chance I’ll double or treble my investment in 30 days? Hell no is the answer.

Avacta nor BBI are recruiting big for this antigen LFT. ODX have 100 staff and possibly 200 in January. Avacta ceo RNS’s when he sends a free test for someone to look at. Avacta bang on about their BAMS test and even that isn’t complete and the industry is moving onto LFT.

This isn’t an invite for AVCT people to start posting here, but fellow ODX poster of the intelligent kind... show me the sales order for BAMS. Or one picture or article with their LFT out in the wild.

I’m in ODX, I’ve argued for Mologic and Antigen LFT but no offence mate. If you think that’s proof then you need your head examining. He may as well have taken a picture of a white piece of wood and said it’s a test.

Kainos

Tell me about it, but like those chums trying to persuade people they are riding a horse and not a donkey at Avacta.

117m is peanuts

The spend on tests will run into the billions.

Merchant is correct. No chance right now for immunity cert of any kind.